T1	Treatment 29 47	soy-based formulas
T2	Treatment 64 81	added nucleotides
T3	Treatment 153 186	soy protein isolate-based formula
T4	Treatment 357 368	Nucleotides
T5	Treatment 476 487	nucleotides
T6	Treatment 491 508	soy-based formula
T7	Treatment 587 615	soy protein isolate formulas
T8	Treatment 639 650	nucleotides
T9	Treatment 741 833	assigned randomly to soy formula groups with and without added nucleotides (n = 94, n = 92).
T10	Treatment 850 893	human milk/formula-fed cohort (n = 81), was
T11	Treatment 917 969	Blood samples were collected at 6, 7, and 12 months.
T12	Treatment 1336 1347	soy formula
T13	Treatment 1352 1374	human milk/formula-fed
T14	Treatment 1573 1596	nucleotide-supplemented
T15	Treatment 1846 1858	nucleotides.
T16	Treatment 2052 2063	nucleotides
